Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Burden of Opioid Use Disorder in the Middle East and North Africa (Mena): Findings From Global Burden of Disease (Gbd) Study Publisher Pubmed



M Efffatpanah MOHAMMAD ; H Seyedmirzaei HOMA ; H Karami HOSSEIN ; P Rasoulian PEGAH ; Rv Mehrizi Reza VALIOLLAHI ; K Danandeh KHASHAYAR ; L Ghamkhar LEILA ; Z Efatpanah ZEYNAB ; A Nakhostinansari AMIN
Authors

Source: Journal of Health, Population and Nutrition Published:2025


Abstract

Background: Opioid Use Disorders (OUDs) present critical health challenges across the Middle East and North Africa (MENA) region. The primary objective of this study is to assess the prevalence and burden of OUDs within the MENA region. Methods: In the current study, we used the Global Burden of Diseases (GBD) 2019 study data. In the GBD study, OUDs were defined as the ICD-10 codes of F11.0-F11.9, P96.1, and R78.1 and the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) code of 304.00. We retrieved the prevalence, death, and disability-adjusted life year (DALY) crude rates and age-standardized rates for OUDs throughout MENA countries, the MENA area, and globally, across years (from 1990 to 2019), genders, and age groups. Results: Age-standardized DALY rate of OUDs in MENA increased by 40.6%, from 104.4 (95% UI: 78.2–136.0) in 1990 to 147.0 (95% UI: 111.8-187.7) per 100,000 people in 2019. In 2019, the highest DALY rate of OUDs for both males (411.3 per 100000) and females (330.2 per 100000) and in total (372.3 per 100000) was in the 25–29 years age group. In 2019, the highest age-standardized DALY rates of OUDs were UAE (373.9 per 100000, 95% UI: 278.2-481.7), Libya (341.1 per 100000, 95% UI: 248.9-435.8), and Iran (281.5 per 100000, 95% UI: 221.1–349.0). Age-standardized DALY rates decreased in Qatar (-10.2%) and Iraq (-1.9%) from 1990 to 2019. While, age-standardized DALY rates increased in other countries, with the highest increases being in Libya (167.3%), Lebanon (121.1%), and UAE (113.31%). Conclusions: The burden of OUDs has increased from 1990 to 2019 in the MENA region. These results necessitate new governmental policies and global collaborations to effectively control opioid production and trafficking and manage their negative health-related outcomes. © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Burden of Substance Use Disorders in the Middle East and North Africa From 1990 to 2019, Balkan Medical Journal (2025)
2. Mortality and Negative Outcomes of Opioid Use and Opioid Use Disorder: A 6-Year Follow-Up Study, Addiction (2022)
3. Drug Use, Drug Use Disorders, and Treatment Services in the Eastern Mediterranean Region: A Systematic Review, The Lancet Psychiatry (2023)
Experts (# of related papers)
View all Related Experts
Afarin Rahimi-Movaghar (7)
Masoumeh Amin-Esmaeili (6)
Other Related Docs
4. Metabolomics Reveals Biomarkers of Opioid Use Disorder, Translational Psychiatry (2021)
5. Epidemiological Study of Mortality Rate From Alcohol and Illicit Drug Abuse in Iran, Journal of Research in Health Sciences (2017)
6. Burden of Diseases and Injuries Attributable to Alcohol Consumption in the Middle East and North Africa Region, 1990–2019, Scientific Reports (2022)
7. Prevalence and Determinants of Opioid Use Disorder Among Long-Term Opiate Users in Golestan Cohort Study, BMC Psychiatry (2023)
8. Risk of Covid-19 Infection and the Associated Hospitalization, Icu Admission and Mortality in Opioid Use Disorder: A Systematic Review and Meta-Analysis, Addiction Science and Clinical Practice (2022)
9. Concurrent Amphetamine and Methamphetamine Use Among Clients of Opioid Maintenance Treatment Programs in Golestan, Iran, Iranian Journal of Psychiatry and Behavioral Sciences (2019)
10. Investigating the Dimensions of Quality of Life, Depression, Anxiety, Stress, and Substance Craving in People With Opioid Use Disorders, Methadone-Maintained Subjects, and Narcotics Anonymous Members, Basic and Clinical Neuroscience (2025)
11. Latent Class Analysis of Dsm-5 Criteria for Opioid Use Disorders: Results From the Iranian National Survey on Mental Health, European Addiction Research (2015)
12. Epidemiology of Illicit Drug Use Disorders in Iran: Prevalence, Correlates, Comorbidity and Service Utilization Results From the Iranian Mental Health Survey, Addiction (Abingdon# England) (2016)
13. A Nationwide Study on Consumption of Opioid Analgesics in Iran From 2000 to 2018, International Journal of Clinical Pharmacy (2023)
14. Burden and Epidemiology of Mental Disorders in the Middle East and North Africa From 1990 to 2019: Findings From the Global Burden of Disease Study, Balkan Medical Journal (2024)
15. Epidemiology of Substance and Opium Use Among Adult Residents of Tehran; a Comprehensive Report From Tehran Cohort Study (Tecs), BMC Psychiatry (2024)
16. Effects of Abstinence From Opioids on Self-Reported Craving and Sleep, Cogent Psychology (2020)
17. Global Scientific Production on Illicit Drug Addiction: A Two-Decade Analysis, European Addiction Research (2018)
18. The Pattern of Medication Use, and Determinants of the Prevalence of Polypharmacy Among Patients With a Recent History of Depressive Disorder: Results From the Pars Cohort Study, BMC Psychology (2022)
19. Burden of Type 2 Diabetes Mellitus and Its Risk Factors in North Africa and the Middle East, 1990–2019: Findings From the Global Burden of Disease Study 2019, BMC Public Health (2024)
20. Prognosis of Covid-19 Infection Among Opium Users in Iran,2020: A Hospital-Based Study, Journal of Substance Use (2024)